Publicaciones en colaboración con investigadores/as de Hospital Clínico San Carlos de Madrid (43)

2024

  1. Preoperative liver regeneration with CD133+ infusion in patients with colorectal liver metastases: proof-of concept trial

    HPB

  2. Repeated pancreatic resection for pancreatic metastases from renal cell Carcinoma: A Spanish multicenter study (PANMEKID)

    Surgical Oncology, Vol. 52

2022

  1. Pancreatic metastases from renal cell carcinoma. Postoperative outcome after surgical treatment in a Spanish multicenter study (PANMEKID)

    European Journal of Surgical Oncology, Vol. 48, Núm. 1, pp. 133-141

  2. Sarcomatoid Transformation of Chromophobe Renal Cell Carcinoma: An Unusual Pathology

    Eurasian Journal of Medicine and Oncology

2021

  1. Aryl hydrocarbon receptor interacting protein (AIP) significantly influences prognosis of pancreatic carcinoma

    Annals of Diagnostic Pathology, Vol. 53

  2. Outcomes from elective colorectal cancer surgery during the SARS-CoV-2 pandemic

    Colorectal Disease, Vol. 23, Núm. 3, pp. 732-749

  3. Preoperative hepatic artery embolization before distal pancreatectomy plus celiac axis resection does not improve surgical results: A Spanish multicentre study

    Surgeon, Vol. 19, Núm. 5, pp. e117-e124

  4. Preoperative nasopharyngeal swab testing and postoperative pulmonary complications in patients undergoing elective surgery during the SARS-CoV-2 pandemic

    British Journal of Surgery, Vol. 108, Núm. 1, pp. 88-96

  5. Sarcomatoid Transformation of Cromophobe Renal Cell Carcinoma: An Unusual Pathology. Our Experience, Definition of Therapeutic Guidelines and Review of Literature

    Eurasian Journal of Medicine and Oncology, Vol. 5, Núm. 4, pp. 361-367

  6. Spanish multicenter study of surgical resection of pancreatic tumors infiltrating the celiac axis: does the type of pancreatectomy affect results?

    Clinical and Translational Oncology, Vol. 23, Núm. 2, pp. 318-324

2020

  1. CD133 + cell infusion in patients with colorectal liver metastases going to be submitted to a major liver resection (CELLCOL): A randomized open label clinical trial

    Surgical Oncology, Vol. 33, pp. 224-230

  2. Resultados de una encuesta sobre el soporte nutricional perioperatorio en la cirugía pancreática y biliar en España

    Nutricion hospitalaria, Vol. 37, Núm. 2, pp. 238-242

  3. Splenic volume as a biomarker of hepatic damage after chemotherapy in patients with resected colorectal liver metastases (CRLM)

    Clinical and Translational Oncology, Vol. 22, Núm. 7, pp. 1180-1186

  4. The clinical significance of PIWIL3 and PIWIL4 expression in pancreatic cancer

    Journal of Clinical Medicine, Vol. 9, Núm. 5

2019

  1. Does the Artery-first Approach Improve the Rate of R0 Resection in Pancreatoduodenectomy?: A Multicenter, Randomized, Controlled Trial

    Annals of Surgery, Vol. 270, Núm. 5, pp. 738-746

  2. Multicentric study on total pancreatectomies

    Cirugia Espanola, Vol. 97, Núm. 7, pp. 377-384

  3. Still a place for conventional histopathological analysis in the era of molecular medicine: predicting prognosis of resectable ductal pancreatic adenocarcinoma

    Clinical and Translational Oncology, Vol. 21, Núm. 7, pp. 954-959

  4. The prognosis value of PIWIL1 and PIWIL2 expression in pancreatic cancer

    Journal of Clinical Medicine, Vol. 8, Núm. 9

2018

  1. Prognostic factors in adenocarcinoma of the ampulla of Vater

    Revista Espanola de Patologia, Vol. 51, Núm. 4, pp. 210-215

2016

  1. Quiste ciliado hepático, diagnóstico diferencial de lesiones hepáticas del segmento IV

    Cirugia Espanola, Vol. 94, Núm. 9, pp. 545-547